Panacea Life Sciences (PLSH) Form 5 PANACEA LIFE SCIENCES / Leslie Buttorff ownership change

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0362
Estimated average burden
hours per response:	1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Buttorff Leslie

(Last) (First) (Middle)

5910 SOUTH UNIVERSITY BLVD, C18-193

(Street)

GREENWOOD VILLAGE CO 80121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PANACEA LIFE SCIENCES HOLDINGS, INC. [ PLSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
Chief Executive Officer

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
Common Stock	01/18/2022		P	1,100	A	$0.713	662,049	D
Common Stock	01/19/2022		P	1,000	A	$0.71	663,049	D
Common Stock	01/20/2022		P	2,300	A	$0.655	665,349	D
Common Stock	01/25/2022		P	700	A	$0.8499	666,049	D
Common Stock	02/11/2022		P	200	A	$0.688	666,249	D
Common Stock	02/16/2022		P	100	A	$0.698	666,349	D
Common Stock	05/16/2022		P	200	A	$0.4159	666,549	D
Common Stock	05/17/2022		P	100	A	$0.4999	666,649	D
Common Stock	05/23/2022		P	100	A	$0.5	666,749	D
Common Stock	06/06/2022		P	300	A	$0.4251	667,049	D
Common Stock	06/14/2022		P	500	A	$0.1821	667,549	D
Common Stock	06/16/2022		P	500	A	$0.126	668,049	D
Common Stock	06/17/2022		P	9,600	A	$0.282	677,649	D
Common Stock	06/21/2022		P	3,700	A	$0.39	681,349	D
Common Stock	06/29/2022		P	2,500	A	$0.2999	683,849	D
Common Stock	07/14/2022		P	200	A	$0.4468	686,549	D
Common Stock	07/15/2022		P	400	A	$0.416	686,949	D
Common Stock	07/22/2022		P	400	A	$0.294	687,349	D
Common Stock	07/26/2022		P	1,100	A	$0.12	688,449	D
Common Stock	08/09/2022		P	1,000	A	$0.1399	689,449	D
Common Stock	08/11/2022		P	2,000	A	$0.126	691,449	D
Common Stock	08/18/2022		P	1,000	A	$0.1699	692,449	D
Common Stock	08/19/2022		P	6,500	A	$0.1569	698,949	D
Common Stock	09/13/2022		P	1,000	A	$0.1005	699,949	D
Common Stock	11/23/2022		P	3,000	A	$0.1	702,949	D
Common Stock	11/29/2022		P	2,000	A	$0.125	704,949	D
Common Stock	12/01/2022		P	1,000	A	$0.095	705,949	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Leslie Buttorff	01/30/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.